Literature DB >> 19851846

Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers.

Archibald Paillard1, Catherine Passirani, Patrick Saulnier, Maya Kroubi, Emmanuel Garcion, Jean-Pierre Benoît, Didier Betbeder.   

Abstract

PURPOSE: Stealth nanoparticles are generally obtained after modifying their surface with hydrophilic polymers, such as PEG. In this study, we analysed the effect of a phospholipid (DG) or protein (BSA) inclusion in porous cationic polysaccharide (NP(+)) on their physico-chemical structure and the effect on complement activation.
METHODS: NP(+)s were characterised in terms of size, zeta potential (zeta) and static light scattering (SLS). Complement consumption was assessed in normal human serum (NHS) by measuring the residual haemolytic capacity of the complement system.
RESULTS: DG loading did not change their size or zeta, whereas progressive BSA loading lightly decreased their zeta. An electrophoretic mobility analysis study showed the presence of two differently-charged sublayers at the NP(+) surface which are not affected by DG loading. Complement system activation, studied via a CH50 test, was suppressed by DG or BSA loading. We also demonstrated that NP(+)s could be loaded by a polyanionic molecule, such as BSA, after their preliminary filling by a hydrophobic molecule, such as DG.
CONCLUSION: These nanoparticles are able to absorb large amounts of phospholipids or proteins without change in their size or zeta potential. Complement studies showed that stealth behaviour is observed when they are loaded and saturated either with anionic phospholipid or proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19851846      PMCID: PMC2901554          DOI: 10.1007/s11095-009-9986-z

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

1.  Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties.

Authors:  Arnaud Béduneau; Patrick Saulnier; Nicolas Anton; François Hindré; Catherine Passirani; Holisoa Rajerison; Nicolas Noiret; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

2.  Characterization of the soluble nanoparticles formed through Coulombic interaction of bovine serum albumin with anionic graft copolymers at low pH.

Authors:  Evaggelia Serefoglou; Julian Oberdisse; Georgios Staikos
Journal:  Biomacromolecules       Date:  2007-02-22       Impact factor: 6.988

3.  Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro.

Authors:  Youssef Jallouli; Archibald Paillard; Jiang Chang; Emmanuel Sevin; Didier Betbeder
Journal:  Int J Pharm       Date:  2007-06-22       Impact factor: 5.875

Review 4.  Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.

Authors:  Daryl C Drummond; Charles O Noble; Mark E Hayes; John W Park; Dmitri B Kirpotin
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

Review 5.  What can light scattering spectroscopy do for membrane-active peptide studies?

Authors:  Marco M Domingues; Patrícia S Santiago; Miguel A R B Castanho; Nuno C Santos
Journal:  J Pept Sci       Date:  2008-04       Impact factor: 1.905

6.  Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake.

Authors:  A Vonarbourg; C Passirani; P Saulnier; P Simard; J C Leroux; J P Benoit
Journal:  J Biomed Mater Res A       Date:  2006-09-01       Impact factor: 4.396

7.  Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier.

Authors:  L Fenart; A Casanova; B Dehouck; C Duhem; S Slupek; R Cecchelli; D Betbeder
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

8.  Novel composite core-shell nanoparticles as busulfan carriers.

Authors:  A Layre; P Couvreur; H Chacun; J Richard; C Passirani; D Requier; J P Benoit; R Gref
Journal:  J Control Release       Date:  2006-02-20       Impact factor: 9.776

9.  Synthesis and pH-dependent micellization of diblock copolymer mixtures.

Authors:  K Van Butsele; P Sibret; C A Fustin; J F Gohy; C Passirani; J-P Benoit; R Jérôme; C Jérôme
Journal:  J Colloid Interface Sci       Date:  2008-10-04       Impact factor: 8.128

10.  Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

Authors:  Alain Razafindratsita; Nathalie Saint-Lu; Laurent Mascarell; Nathalie Berjont; Thierry Bardon; Didier Betbeder; Laurence Van Overtvelt; Philippe Moingeon
Journal:  J Allergy Clin Immunol       Date:  2007-05-25       Impact factor: 10.793

View more
  8 in total

1.  Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells.

Authors:  Jiang Chang; Archibald Paillard; Catherine Passirani; Marie Morille; Jean-Pierre Benoit; Didier Betbeder; Emmanuel Garcion
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.

Authors:  B Bernocchi; R Carpentier; I Lantier; C Ducournau; I Dimier-Poisson; D Betbeder
Journal:  J Control Release       Date:  2016-04-11       Impact factor: 9.776

Review 3.  Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers.

Authors:  Giuliana Muraca; Ignacio Rivero Berti; María L Sbaraglini; Wagner J Fávaro; Nelson Durán; Guillermo R Castro; Alan Talevi
Journal:  Front Chem       Date:  2020-11-26       Impact factor: 5.221

4.  Starch nanoparticles improve curcumin-induced production of anti-inflammatory cytokines in intestinal epithelial cells.

Authors:  Norhane Salah; Laurent Dubuquoy; Rodolphe Carpentier; Didier Betbeder
Journal:  Int J Pharm X       Date:  2022-03-08

5.  Starch-based NP act as antigen delivery systems without immunomodulating effect.

Authors:  François Fasquelle; Laurent Dubuquoy; Didier Betbeder
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

6.  Facilitated and Controlled Strontium Ranelate Delivery Using GCS-HA Nanocarriers Embedded into PEGDA Coupled with Decortication Driven Spinal Regeneration.

Authors:  Chih-Wei Chiang; Chih-Hwa Chen; Yankuba B Manga; Shao-Chan Huang; Kun-Mao Chao; Pei-Ru Jheng; Pei-Chun Wong; Batzaya Nyambat; Mantosh Kumar Satapathy; Er-Yuan Chuang
Journal:  Int J Nanomedicine       Date:  2021-06-22

7.  Porous Nanoparticles With Self-Adjuvanting M2e-Fusion Protein and Recombinant Hemagglutinin Provide Strong and Broadly Protective Immunity Against Influenza Virus Infections.

Authors:  Valentina Bernasconi; Beatrice Bernocchi; Liang Ye; Minh Quan Lê; Ajibola Omokanye; Rodolphe Carpentier; Karin Schön; Xavier Saelens; Peter Staeheli; Didier Betbeder; Nils Lycke
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

8.  Effective Nanoparticle-Based Nasal Vaccine Against Latent and Congenital Toxoplasmosis in Sheep.

Authors:  Céline Ducournau; Nathalie Moiré; Rodolphe Carpentier; Pauline Cantin; Clément Herkt; Isabelle Lantier; Didier Betbeder; Isabelle Dimier-Poisson
Journal:  Front Immunol       Date:  2020-09-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.